source
- Cytospire hauls in $83M for a new type of T cell engagerThe British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.BioPharma Dive · 3mo ago↗ source
- Vertex drops mRNA cystic fibrosis program over 'tolerability' issuesVertex Pharmaceuticals said it has dropped development of an mRNA-based cystic fibrosis therapy after facing challenges similar to those that have troubled other parts of the field in delivering th…Endpoints · 3mo ago↗ source
- FDA search for new CBER head focused on small group of final candidatesThe FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three or four final candidates, according to a person familiar with the matter. The agency ho…